215 related articles for article (PubMed ID: 29561193)
1. ESTROGEN LEVELS DO NOT RISE WITH TESTOSTERONE TREATMENT FOR TRANSGENDER MEN.
Chan KJ; Jolly D; Liang JJ; Weinand JD; Safer JD
Endocr Pract; 2018 Apr; 24(4):329-333. PubMed ID: 29561193
[TBL] [Abstract][Full Text] [Related]
2. PROLACTIN LEVELS DO NOT RISE AMONG TRANSGENDER WOMEN TREATED WITH ESTRADIOL AND SPIRONOLACTONE.
Bisson JR; Chan KJ; Safer JD
Endocr Pract; 2018 Jul; 24(7):646-651. PubMed ID: 29708436
[TBL] [Abstract][Full Text] [Related]
3. TESTOSTERONE LEVELS ACHIEVED BY MEDICALLY TREATED TRANSGENDER WOMEN IN A UNITED STATES ENDOCRINOLOGY CLINIC COHORT.
Liang JJ; Jolly D; Chan KJ; Safer JD
Endocr Pract; 2018 Feb; 24(2):135-142. PubMed ID: 29144822
[TBL] [Abstract][Full Text] [Related]
4. Effects of cross-sex hormone treatment on transgender women and men.
Deutsch MB; Bhakri V; Kubicek K
Obstet Gynecol; 2015 Mar; 125(3):605-610. PubMed ID: 25730222
[TBL] [Abstract][Full Text] [Related]
5. Lower Serum Estradiol Levels in Assigned Female at Birth Transgender People with Initiation of Testosterone Therapy: Results from the European Network for the Investigation of Gender Incongruence.
Defreyne J; Aers XP; Collet SM; Wiepjes CM; Fisher AD; Schreiner T; Den Heijer M; Kaufman JM; T'Sjoen GGR
LGBT Health; 2020; 7(2):71-81. PubMed ID: 32049583
[No Abstract] [Full Text] [Related]
6. EXOGENOUS TESTOSTERONE DOES NOT INDUCE OR EXACERBATE THE METABOLIC FEATURES ASSOCIATED WITH PCOS AMONG TRANSGENDER MEN.
Chan KJ; Liang JJ; Jolly D; Weinand JD; Safer JD
Endocr Pract; 2018 Jun; 24(6):565-572. PubMed ID: 29624102
[TBL] [Abstract][Full Text] [Related]
7. Changes in hormonal and metabolic parameters in transgender subjects on cross-sex hormone therapy: A cohort study.
Vita R; Settineri S; Liotta M; Benvenga S; Trimarchi F
Maturitas; 2018 Jan; 107():92-96. PubMed ID: 29169588
[TBL] [Abstract][Full Text] [Related]
8. Assessment of Gender-Affirming Hormone Therapy Requirements.
Fernandez JD; Kendjorsky K; Narla A; Villasante-Tezanos AG; Tannock LR
LGBT Health; 2019 Apr; 6(3):101-106. PubMed ID: 30810452
[TBL] [Abstract][Full Text] [Related]
9. The effect of testosterone on ovulatory function in transmasculine individuals.
Taub RL; Ellis SA; Neal-Perry G; Magaret AS; Prager SW; Micks EA
Am J Obstet Gynecol; 2020 Aug; 223(2):229.e1-229.e8. PubMed ID: 32044312
[TBL] [Abstract][Full Text] [Related]
10. SERUM HORMONE CONCENTRATIONS IN TRANSGENDER INDIVIDUALS RECEIVING GENDER-AFFIRMING HORMONE THERAPY: A LONGITUDINAL RETROSPECTIVE COHORT STUDY.
Chantrapanichkul P; Stevenson MO; Suppakitjanusant P; Goodman M; Tangpricha V
Endocr Pract; 2021 Jan; 27(1):27-33. PubMed ID: 33471729
[TBL] [Abstract][Full Text] [Related]
11. Urine and Serum Sex Steroid Profile in Testosterone-Treated Transgender and Hypogonadal and Healthy Control Men.
Savkovic S; Lim S; Jayadev V; Conway A; Turner L; Curtis D; Goebel C; Handelsman DJ
J Clin Endocrinol Metab; 2018 Jun; 103(6):2277-2283. PubMed ID: 29584875
[TBL] [Abstract][Full Text] [Related]
12. Prospective evaluation of hematocrit in gender-affirming hormone treatment: results from European Network for the Investigation of Gender Incongruence.
Defreyne J; Vantomme B; Van Caenegem E; Wierckx K; De Blok CJM; Klaver M; Nota NM; Van Dijk D; Wiepjes CM; Den Heijer M; T'Sjoen G
Andrology; 2018 May; 6(3):446-454. PubMed ID: 29602229
[TBL] [Abstract][Full Text] [Related]
13. Effects of testosterone on the transgender male voice.
Irwig MS; Childs K; Hancock AB
Andrology; 2017 Jan; 5(1):107-112. PubMed ID: 27643399
[TBL] [Abstract][Full Text] [Related]
14. Reproductive Endocrinology Reference Intervals for Transgender Women on Stable Hormone Therapy.
Greene DN; Schmidt RL; Winston McPherson G; Rongitsch J; Imborek KL; Dickerson JA; Drees JC; Humble RM; Nisly N; Dole NJ; Dane SK; Frerichs J; Krasowski MD
J Appl Lab Med; 2021 Jan; 6(1):15-26. PubMed ID: 32674116
[TBL] [Abstract][Full Text] [Related]
15. Prospective Evaluation of Self-Reported Aggression in Transgender Persons.
Defreyne J; T'Sjoen G; Bouman WP; Brewin N; Arcelus J
J Sex Med; 2018 May; 15(5):768-776. PubMed ID: 29699761
[TBL] [Abstract][Full Text] [Related]
16. The Impact of Exogenous Testosterone on Breast Cancer Risk in Transmasculine Individuals.
Gurrala RR; Kumar T; Yoo A; Mundinger GS; Womac DJ; Lau FH
Ann Plast Surg; 2023 Jan; 90(1):96-105. PubMed ID: 36534108
[TBL] [Abstract][Full Text] [Related]
17. Reproductive Endocrinology Reference Intervals for Transgender Men on Stable Hormone Therapy.
Greene DN; Schmidt RL; Winston-McPherson G; Rongitsch J; Imborek KL; Dickerson JA; Drees JC; Humble RM; Nisly N; Dole NJ; Dane SK; Frerichs J; Krasowski MD
J Appl Lab Med; 2021 Jan; 6(1):41-50. PubMed ID: 33241847
[TBL] [Abstract][Full Text] [Related]
18. Sex Steroids Regulate Liver Fat Content and Body Fat Distribution in Both Men and Women: A Study in Transgender Persons.
Tebbens M; Schutte M; Troelstra MA; Bruinstroop E; de Mutsert R; Nederveen AJ; den Heijer M; Bisschop PH
J Clin Endocrinol Metab; 2023 Dec; 109(1):e280-e290. PubMed ID: 37463488
[TBL] [Abstract][Full Text] [Related]
19. Headache prevalence in transgender and gender diverse youth: A single-center case-control study.
Hranilovich JA; Millington K
Headache; 2023 Apr; 63(4):517-522. PubMed ID: 36988085
[TBL] [Abstract][Full Text] [Related]
20. Testosterone substitution normalizes elevated serum leptin levels in hypogonadal men.
Jockenhövel F; Blum WF; Vogel E; Englaro P; Müller-Wieland D; Reinwein D; Rascher W; Krone W
J Clin Endocrinol Metab; 1997 Aug; 82(8):2510-3. PubMed ID: 9253326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
